Literature DB >> 32152521

HIV-positive women with anal high-grade squamous intraepithelial lesions: a study of 153 cases with long-term anogenital surveillance.

Yuxin Liu1, Monica Prasad-Hayes2, Eric M Ganz2, Juan Lucas Poggio3, Volha Lenskaya4, Threshia Malcolm3, Ashish Deshmukh5, Wenxin Zheng6, Keith Sigel7, Michael M Gaisa8.   

Abstract

Women living with HIV (WLHIV) are at increased risk for human papillomavirus (HPV)-associated anal cancer. Given the "field effect" of HPV pathogenesis, some recommend that anal cancer screening should be limited to WLHIV with prior genital disease. This study aimed to characterize the relationship between anal and genital disease in WLHIV in order to better inform anal cancer screening guidelines. We retrospectively studied 153 WLHIV with biopsy-proven anal high-grade squamous intraepithelial lesions (AHSIL) and long-term evaluable cervical/vaginal/vulvar histopathology. Based on the absence or presence of genital HSIL, subjects were categorized as having isolated AHSIL or multicentric HSIL. Demographics, HIV parameters and cervical/anal HPV status were recorded. Chi-square test was used for bivariate analyses. Of 153 WLHIV with AHSIL, 110 (72%) had isolated AHSIL, while 43 (28%) had multicentric HSIL (28 cervical, 16 vulvar, and 8 vaginal HSIL). The median genital surveillance was 8 years (range 1-27). Cervical HPV16/18 infection was associated with multicentric disease (P = 0.001). Overall, 53% of multicentric cases presented genital HSIL preceding AHSIL with median interval 13 years (range 2-23). Paired anal and cervical high-risk HPV results were available for 60 women within 12 months of AHSIL diagnosis: 30 (50%) had anal infection alone, while 30 (50%) had anal/cervical coinfection by 16/18 (15%), non-16/18 (13%), or different types (22%). In conclusion, WLHIV frequently develop AHSILs without pre-existing genital disease or after long latency following a genital HSIL diagnosis. Our findings support anal cancer screening for WLHIV irrespective of prior genital disease.

Entities:  

Mesh:

Year:  2020        PMID: 32152521     DOI: 10.1038/s41379-020-0518-z

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   8.209


  3 in total

1.  A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial.

Authors:  Stephen E Goldstone; Shelly Y Lensing; Elizabeth A Stier; Teresa Darragh; Jeannette Y Lee; Annemieke van Zante; Naomi Jay; J Michael Berry-Lawhorn; Ross D Cranston; Ronald Mitsuyasu; David Aboulafia; Joel M Palefsky; Timothy Wilkin
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

2.  Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).

Authors:  Erna Milunka Kojic; Susan Cu-Uvin; Lois Conley; Tim Bush; Juanita Onyekwuluje; David C Swan; Elizabeth R Unger; Keith Henry; John H Hammer; Edgar T Overton; Teresa M Darragh; Joel M Palefsky; Claudia Vellozzi; Pragna Patel; John T Brooks
Journal:  Sex Transm Dis       Date:  2011-04       Impact factor: 2.830

Review 3.  Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments.

Authors:  Alex Ferenczy; François Coutlée; Eduardo Franco; Catherine Hankins
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.